No Data
Ardelyx, Inc.'s (NASDAQ:ARDX) Recent 6.4% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
World IBS Day - April 19th: Educating Others About Irritable Bowel Syndrome
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
Piper Sandler Initiates Ardelyx(ARDX.US) With Hold Rating, Announces Target Price $8
Piper Sandler Sticks to Their Hold Rating for Ardelyx (ARDX)
Possible Bearish Signals With Ardelyx Insiders Disposing Stock